You are receiving this message as a subscriber to the FDA HIV/AIDS electronic list serve. The purpose of the list serve is to relay important information about HIV/AIDS-related products and issues, including product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings and alerts to proposed regulatory guidances for comment.
Please do not reply to this message.
On December 29, 2008 FDA granted approval for three generic fomulations of stavudine. Stavudine is a Nucleoside Reverse Transcriptase Inhibitors (NRTI), which helps keep HIV, the virus that causes AIDS, from reproducing. It is intended to be used in combination with other anti-retroviral agents for the treatment of HIV-1 infection.
The approved generic formulations are stavudine capsules (15 mg, 20 mg, 30 mg and 40 mg), and Stavudine for Oral Solution (1 mg/mL), both manufactured by Aurobindo Pharma; and stavudine capsules (15 mg, 20 mg, 30 mg and 40 mg) manufactured by Hetero Drugs Limited, both of Hyberdad, India.
FDA has determined that Aurobindo's stavudine for oral solution and stavudine capsules are bioequivalent and, therefore, therapeutically equivalent to Zerit oral solution 1mg/mL and 15 mg, 20 mg, 30 mg, and 40 mg capsules, respectively, made by Bristol-Myers Squibb.
Similarly, Hetero's stavudine capsules were determined to be bioequivalent, and thus therapeutically equivalent to Zerit Capsules, 15 mg, 20 mg, 30 mg, and 40 mg.
The patent and pediatric exclusivity protections associated with the originator product have expired, so these generic formulations are approved for marketing in the United States.
Richard Klein
Office of Special Health Issues
Food and Drug Administration
Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
No comments:
Post a Comment